CGRP Antagonists Market: Revolutionizing Small-Molecule Gepants, Biologic Injectables, and Clinical Workflows
Surging global prevalence of chronic and episodic migraines, expanding patient and physician demand for non-triptan targeted therapies, and continuous biopharmaceutical innovations in calcitonin gene-related peptide (CGRP) monoclonal antibodies and small-molecule oral gepants are driving rapid growth across the global CGRP Antagonists Market. CGRP antagonist solutions—comprising monthly...
0 Commentarii 0 Distribuiri 6 Views 0 previzualizare
social art-inpa https://social.art-inpa.com